Aimmune Therapeutics, Inc.

Quick facts

Phase 2 pipeline

• AR101 - Peanut protein capsule · Immunology
  AR101 works by desensitizing the immune system to peanut protein, allowing individuals with peanut allergies to safely consume peanuts.
• AR101 powder provided in capsules · Allergy
  AR101 is an oral immunotherapy for peanut allergy.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aimmune Therapeutics, Inc. portfolio CI brief
• Aimmune Therapeutics, Inc. pipeline updates RSS